{"schema_version":"secwatch.filing_event.v1","accession":"0000313143-24-000060","form_type":"8-K","ticker":"HAE","cik":"0000313143","company_name":"HAEMONETICS CORP","filed_at":"2024-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.681775+00:00","generated_at":"2026-05-30T04:02:05.289070+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"Haemonetics announces Q2 FY2025 results; specific figures unavailable from provided filing text","bullets":["Company issued press release for quarter ended Sept 28, 2024 and first half of fiscal 2025.","No revenue, EPS, or segment data are included in the 8-K filing text provided.","Investors should consult the full press release for detailed financial results.","CEO Christopher A. Simon signed the Form 8-K on November 7, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0000313143-24-000060","json":"https://secwatch.observer/filing/0000313143-24-000060.json","markdown":"https://secwatch.observer/filing/0000313143-24-000060.md","text":"https://secwatch.observer/filing/0000313143-24-000060.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/313143/000031314324000060/0000313143-24-000060-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/313143/000031314324000060/hae-20241107.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T04:02:05.289070+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}